|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in Regulation of Calcium Transients in Diabetic Vascular Smooth Muscle Cells
1 Department of Medicine, Dorrance Hamilton Research Laboratories, Division of NephrologyThomas Jefferson University, Philadelphia, PA, USA
2 Department of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands
3 Department of Anatomy, Pathology and Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA
4 Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA, USA
* To whom correspondence should be addressed. E-mail: kumar.sharma{at}mail.tju.edu.
Altered calcium [Ca2+] transients of vascular smooth muscle cells to vasoconstrictors may contribute to altered regulation of blood flow in diabetes. We postulated that diabetes-induced TGF-
production contributes to impaired Ang II response of vascular smooth muscle cells in macrovessels and microvessels. Aortic vascular smooth muscle cells isolated from diabetic rats exhibited markedly impaired Ang II-induced cytosolic calcium [Ca2+] signal that was completely restored by pre-treatment with anti-TGF-
antibodies. Similar findings were noted in microvascular smooth muscle cells isolated from pre-glomerular vessels and cultured in high glucose. The impact of diabetes on [Ca2+] transients was replicated by addition of TGF-
1 and -
2 isoforms to aortic smooth muscle cells in culture and diabetic cells had enhanced production of TGF-
2. In the in vivo condition, TGF-
1 was increased in diabetic glomeruli whereas TGF-
2 was increased in diabetic aorta. The characteristic increase in glomerular filtration surface area found in diabetic rats was prevented by treatment with anti-TGF-
antibodies and impaired Ang II-induced aortic ring contraction in diabetic rats was completely restored by anti-TGF-
antibodies. Impaired vascular dysfunction may be partly due to decreased inositol 1,4,5-trisphosphate receptor, as reduced type I IP3R expression was found in diabetic aorta and restored by anti-TGF-
antibodies. We conclude that TGF-
plays an important role in the vascular dysfunction of early diabetes by inhibiting calcium transients in vascular smooth muscle cells.
This article has been cited by other articles:
![]() |
P. Pacher, K. Sharma, G. Csordas, Y. Zhu, and G. Hajnoczky Uncoupling of ER-mitochondrial calcium communication by transforming growth factor-{beta} Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1303 - F1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. R. Rao, R. Wassell, M. A. Shaw, and K. Sharma Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1182 - F1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hu, S. P. RamachandraRao, S. Siva, C. Valancius, Y. Zhu, K. Mahadev, I. Toh, B. J. Goldstein, M. Woolkalis, and K. Sharma Reactive oxygen species production via NADPH oxidase mediates TGF-{beta}-induced cytoskeletal alterations in endothelial cells Am J Physiol Renal Physiol, October 1, 2005; 289(4): F816 - F825. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, M. Casado, S. Vaulont, and K. Sharma Role of Upstream Stimulatory Factors in Regulation of Renal Transforming Growth Factor-{beta}1 Diabetes, July 1, 2005; 54(7): 1976 - 1984. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sharma, A. Cook, M. Smith, C. Valancius, and E. W. Inscho TGF-{beta} impairs renal autoregulation via generation of ROS Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1069 - F1077. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |